Menu
Adapting cervical cancer screening programmes to HPV vaccinated birth cohorts
Summary
Data on HPV vaccination coverage, screening attendance, cervical cancer related burden and healthcare costs, and sexual activity when available, will be systematically collected in reference countries. The data will be transformed for model input. The cervical cancer screening model will be adjusted to these reference countries and validated using selected reference countries. A set of screening scenarios will be modelled to identify feasible and optimal scenarios for each reference country.
This task will be led by THL, Finland.
Subscribe to our newsletter to get news and updates.
Subscribe to our newsletter to get news and updates.
Views and opinions expressed are however those of the author(s) only and do not necessarily reflect those of the European Union or European Health and Digital Executive Agency (HADEA). Neither the European Union nor HADEA can be held responsible for them.
The general objective of EUCanScreen is to assure sustainable implementation of high-quality screening for breast, cervical and colorectal cancers, as well as implementation of the recently recommended screening programs – for lung, prostate and gastric cancers. EUCanScreen will facilitate the reduction of cancer burden and achieving equity across the EU.
This project has received funding from the European Union’s EU4HEALTH Programme under the Grant Agreement no 101162959
